| ₹ crore | Q4 FY21 | Q4 FY20 | Change |
|---|---|---|---|
| Revenue | 200 | 170 | +17.3% |
| EBITDA | 9.3 | 3.1 | +201.3% |
| EBITDA margin | 4.7% | 1.8% | +2.8 pts |
| Profit before tax | 7.2 | 1.6 | +354.7% |
| Net profit | 3.8 | −0.1 | — |
| EPS | ₹0.96 | −₹0.03 | — |
Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast 12M | FY21Mar 2021 | FY20Mar 2020 | FY19Mar 2019 | FY18Mar 2018 | FY17 and earlierAlpha Plus |
|---|
| 196 | — | — | — | — | FY17 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 0.1 | 0.1 | 0.1 | 0.1 | 12.6 | ||
| 0.4 | 0.4 | 0.4 | 0.4 | 97.0 | ||
| 196 | — | — | — | — | ||
| 542 | 542 | 699 | 820 | 740 | ||
| — | −22.5% | −14.8% | +10.9% | — | ||
| 8.5 | 8.5 | 11.3 | 1.4 | 1.0 | ||
| 1.6% | 1.6% | 1.6% | 0.2% | 0.1% | ||
| −1.5 | −1.5 | 1.2 | −4.8 | −4.1 | ||
| −3.2 | −3.2 | 0.4 | 0.1 | 1.2 | ||
| −0.6% | −0.6% | 0.1% | 0.0% | 0.2% | ||
| −₹0.82 | −₹0.81 | ₹0.09 | ₹0.03 | ₹0.29 | ||
| — | −988.9% | +176.9% | −88.7% | — | ||
| — | 30.9 | −36.9 | 19.6 | −11.7 | ||
| — | −2.1 | −5.2 | −3.8 | −13.3 | ||
| 28.9 | 28.9 | −42.2 | 15.8 | −25.0 | ||
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY18 31/03/2018 | FY19 31/03/2019 | FY20 31/03/2020 | FY21 31/03/2021 | Current/LTM TTM · last close | |
|---|---|---|---|---|---|---|
| Market Capitalization | — | — | — | — | 196.1 | |
| - Cash, Equiv & ST Investments | 12.6 | 0.1 | 0.1 | 0.1 | 0.1 | |
| + Total Debt | 97.0 | 0.4 | 0.4 | 0.4 | 0.4 | |
| Enterprise Value | — | — | — | — | 196.4 | |
| Revenue | 739.9 | 820.3 | 698.9 | 541.6 | 541.6 | |
| Growth %, YoY | — | +10.9 | -14.8 | -22.5 | — | |
| EBITDA | 1.0 | 1.4 | 11.3 | 8.5 | 8.5 | |
| Margin % | 0.14 | 0.18 | 1.62 | 1.56 | 1.56 | |
| EBIT | -4.1 | -4.8 | 1.2 | -1.5 | -1.5 | |
| Net Income | 1.2 | 0.1 | 0.4 | -3.2 | -3.2 | |
| Margin % | 0.16 | 0.02 | 0.05 | -0.59 | -0.59 | |
| EPS, Adj (current shares) | 0.29 | 0.03 | 0.09 | -0.81 | -0.82 | |
| Growth %, YoY | — | -88.7 | +176.9 | -988.9 | — | |
| Cash from Operations | -11.7 | 19.6 | -36.9 | 30.9 | — | |
| Capital Expenditures | -13.3 | -3.8 | -5.2 | -2.1 | — | |
| Free Cash Flow | -25.0 | 15.8 | -42.2 | 28.9 | 28.9 | |
Figures from the company's filings with NSE
In FY21 its consolidated net loss was ₹3.2 crore on revenue of ₹542 crore. Promoters held 39.85% of the shares on 30 June 2021.
Sicagen India's basic earnings per share (EPS) were −₹0.81 in FY21. Over the last four quarters (Q1 FY21 to Q4 FY21) they add up to −₹0.81.
In 2026, Sicagen India has declared one dividend: ₹1 with record date 10 September 2026.
Promoters held 39.85% of Sicagen India on 30 June 2021, unchanged from the previous quarter and down 1.94 percentage points from 41.79% a year earlier, according to the shareholding pattern filed with NSE.
In FY21, Sicagen India generated ₹30.9 crore of cash from operations and spent ₹2.1 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹28.9 crore. In FY20 it was −₹42.2 crore.
Sicagen India's latest results are for Q4 FY21 (January–March 2021): consolidated net profit ₹3.8 crore, against a loss of ₹12 lakh in Q4 FY20; revenue from operations ₹200 crore, up 17.3% year on year.
In FY21 (April 2020–March 2021), Sicagen India's consolidated net loss was ₹3.2 crore, against a profit of ₹36 lakh in FY20, on revenue from operations of ₹542 crore (down 22.5%).
From Sicagen India's own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 29 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.